Fate Therapeutics (FATE) Earnings
|
Expand Research on FATE
| Next EPS Date | 5/1/24 | EPS Growth Rate | -152.6% |
|---|---|---|---|
| Average EPS % Beat Rate | +27.2% | Revenue Growth Rate | -97.1% |
| Average % Move 1-Wk after EPS | -5.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/1/24 | Q124 | N/A | -$0.48 | N/A | N/A | $1.71M | N/A | N/A | N/A | ||
| 2/26/24 | Q423 | -$0.45 | -$0.52 | +$0.07 | $1.7M | $1.62M | N/A |  | | Details | |
| 11/8/23 | Q323 | -$0.46 | -$0.56 | +$0.10 | $1.94M | $1.59M | N/A | | | Details | |
8/2/23  |
Q223 | N/A | -$0.59 | N/A | N/A | $5.41M | N/A | N/A | N/A | ||
| 8/8/23 | Q223 | -$0.54 | -$0.59 | +$0.05 | $930K | $5.41M | N/A | | | Details | |
| 5/3/23 | Q123 | -$0.19 | -$0.61 | +$0.42 | $58.98M | $31.21M | N/A | | | Details | |
| 2/28/23 | Q422 | -$0.58 | -$0.86 | +$0.28 | $44.34M | $17.88M | N/A | | | Details | |
| 11/3/22 | Q322 | -$0.86 | -$0.89 | +$0.03 | $14.98M | $15.71M | N/A | | | Details |
